Met Life Investment Management, LLC Aclaris Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 09, 2024	BUY	$6.56 - $10.95 $8,272 - $13,807	1,261 Added 3.72%	35,160 $240,000
Q2 2023 Apr 29, 2024	BUY	$7.89 - $10.64 $277,412 - $374,102	35,160 New	35,160 $364,000
Q2 2023 Aug 10, 2023	BUY	$7.89 - $10.64 $9,949 - $13,417	1,261 Added 3.72%	35,160 $364,000
Q1 2023 May 09, 2024	BUY	$7.07 - $17.95 $239,665 - $608,487	33,899 New	33,899 $274 Million
Q4 2022 May 10, 2024	BUY	$14.33 - $18.37 $37,659 - $48,276	2,628 Added 8.4%	33,899 $533,000
Q4 2022 Mar 22, 2023	BUY	$14.33 - $18.37 $37,659 - $48,276	2,628 Added 8.4%	33,899 $533,000
Q4 2022 Feb 15, 2023	BUY	$14.33 - $18.37 $37,659 - $48,276	2,628 Added 8.4%	33,899 $533,000
Q3 2022 Jun 14, 2023	SELL	$13.07 - $18.22 $34,347 - $47,882	-2,628 Reduced 7.75%	31,271 $492,000
Q2 2022 May 10, 2024	BUY	$10.16 - $17.08 $50,688 - $85,212	4,989 Added 18.98%	31,271 $436,000
Q2 2022 Jun 20, 2023	SELL	$10.16 - $17.08 $26,700 - $44,886	-2,628 Reduced 7.75%	31,271 $436,000
Q2 2022 Mar 22, 2023	BUY	$10.16 - $17.08 $50,688 - $85,212	4,989 Added 18.98%	31,271 $436,000
Q2 2022 Aug 11, 2022	BUY	$10.16 - $17.08 $50,688 - $85,212	4,989 Added 18.98%	31,271 $437,000
Q1 2022 May 10, 2024	BUY	$9.74 - $17.92 $255,986 - $470,973	26,282 New	26,282 $453,000
Q1 2022 Jun 20, 2023	SELL	$9.74 - $17.92 $74,189 - $136,496	-7,617 Reduced 22.47%	26,282 $453,000
Q1 2022 Mar 22, 2023	BUY	$9.74 - $17.92 $94,478 - $173,824	9,700 Added 58.5%	26,282 $453,000
Q1 2022 May 12, 2022	BUY	$9.74 - $17.92 $94,478 - $173,824	9,700 Added 58.5%	26,282 $453,000
Q4 2021 Jun 21, 2023	SELL	$12.27 - $18.49 $212,479 - $320,191	-17,317 Reduced 51.08%	16,582 $241,000
Q3 2021 Jun 21, 2023	SELL	$13.38 - $18.8 $231,701 - $325,559	-17,317 Reduced 51.08%	16,582 $298,000
Q2 2021 May 17, 2024	BUY	$17.08 - $29.6 $283,220 - $490,827	16,582 New	16,582 $291,000
Q2 2021 Jun 21, 2023	SELL	$17.08 - $29.6 $295,774 - $512,583	-17,317 Reduced 51.08%	16,582 $291,000
Q2 2021 Mar 22, 2023	BUY	$17.08 - $29.6 $58,498 - $101,380	3,425 Added 26.03%	16,582 $291,000
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $283,220 - $490,827	16,582 New	16,582 $291,000
Q1 2019 May 15, 2019	SELL	$5.63 - $7.84 $74,073 - $103,150	-13,157 Closed	0 $0
Q4 2018 Jul 13, 2023	SELL	$6.3 - $15.4 $130,674 - $319,426	-20,742 Reduced 61.19%	13,157 $97,000
Q4 2018 Mar 22, 2023	SELL	$6.3 - $15.4 $56,832 - $138,923	-9,021 Reduced 40.68%	13,157 $97,000
Q4 2018 Feb 14, 2019	SELL	$6.3 - $15.4 $56,832 - $138,923	-9,021 Reduced 40.68%	13,157 $97,000
Q3 2018 Jul 13, 2023	SELL	$14.38 - $20.89 $298,269 - $433,300	-20,742 Reduced 61.19%	13,157 $191,000
Q3 2018 Mar 22, 2023	SELL	$14.38 - $20.89 $168,547 - $244,851	-11,721 Reduced 34.58%	22,178 $322,000
Q3 2018 Nov 14, 2018	BUY	$14.38 - $20.89 $129,721 - $188,448	9,021 Added 68.56%	22,178 $322,000
Q2 2018 Aug 15, 2018	BUY	$16.46 - $20.33 $53,396 - $65,950	3,244 Added 32.72%	13,157 $263,000
Q4 2017 Feb 15, 2018	BUY	$21.47 - $27.8 $212,832 - $275,581	9,913	9,913 $244,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$54.4 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$17.9 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$12.9 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$11.5 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$10.5 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account